Neuromuscular complications of the human immunodeficiency virus type 1 infection

Seminars in Neurology

Volumn 19, Issue 2, 1999, Pages 157-164

  Wulff, Enrique A ^a   Simpson, David M ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

AIDS; Myopathy; Neuropathy

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AUTONOMIC NEUROPATHY; DISEASE ASSOCIATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MONONEUROPATHY; MYOPATHY; NEUROLOGIC DISEASE; NEUROMUSCULAR DISEASE; PERIPHERAL NEUROPATHY; POLYNEUROPATHY; POLYRADICULITIS; PRIORITY JOURNAL; REVIEW;

EID: 0032880276     PISSN: 02718235     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1040833     Document Type: Review

References (51)

1. Simpson DM, Katzenstem DA, Hughes MD, et al. Neu-romuscular function in HIV infection: Analysis of a placebo-controlled combination antiretroviral trial. AIDS 1998;12:2425-2432
2. Tagliati M, Grinnel J, Goldbold J, et al. Peripheral nerve function in HIV infection: Clinical, electrophysiologic, and laboratory findings. Arch Neurol 1999;56:84-89
3. Snider WD, Simpson DM, Nielsen S, et al. Neurological complications of acquired immunodeficiency syndrome: Analysis of 50 patients. Ann Neurol 1983;14:403-418
4. So YT, Holtzman DM, Abrams DJ, et al. Peripheral neuropathy associated with acquired immunodeficiency syndrome: Prevalence and clinical features from a population-based survey. Arch Neurol 1988;45:945-948
5. Simpson DM, Olney RK. Peripheral neuropathies associated with human immunodeficiency virus infection. In: Dyck PJ. ed. Peripheral neuropathies: New concepts and treatments. Philadelphia: W.B. Saunders, 1992:685-711
6. Wulff EA, Simpson DM. HIV-associated neuropathy: Recent advances in management. HIV Adv Res Ther 1998;8:23-29
7. Bacellar H, Munoz A, Miller EN, et al. Temporal trends in the incidence of HIV-1 related neurologic diseases: Multicenter AIDS 1 Cohort Study, 1985-1992. Neurology 1994;44:1892-1900
8. Leger JM, Bouche P, Bolgert F, et al. The spectrum of polyneuropathies in patients infected with HIV. J Neurol Neurosurg Psychiatry 1989;52:1369-1374
9. Barohn RJ, Gronseth GS, LeForce BR, et al. Peripheral nervous System involvement in a large cohort of human immunodeficiency virus-infected individuals. Arch Neurol 1993;50:167-171
10. Cornhlath DR, McArthur JC. Predominantly sensory neuropathy in patients with AIDS and AIDS-related complex. Neurology 1988;38:794-796
11. Dal Pan GJ, Glass JD, McArthur JC. Clinicopathologic correlations of HIV-1 associated vacuolar myelopathy: An autopsy based case-control study. Neurology 1994;44:2159-2164
12. Apostolski S, McAlarney T, Quattrini A, et al. The gp120 glycoprotein of human immunodeficiency virus type 1 binds to sensory ganglion neurons. Ann Neurol 1993;34:855-863
13. Yoshioka M, Shapshak P, Srivasta AK, et al. Expression of HIV-1 and interleukin-6 in lumbosacral dorsal root ganglia of patients with AIDS. Neurology 1994;44:1120-1130
14. Gill P, Rarick M, Bernstein-Singer M, et al. Treatment of advanced Kaposi's sarcoma using combination of bleomycin and vincristine. Am J Clin Oncol 1990;13:315-319
15. Figg WD. Peripheral neuropathy in HIV patients after isoniazid therapy. Drug Intel Clin Pharmacol 1991;25:100-101
16. Ochonoski S, Verroust J, Bastuji-Garin S, et al. Thalidomide neuropathy: Incidence and clinicoelectrophysiological findings in 42 patients. Arch Dermatol 1994;130:66-69
17. Simpson DM, Tagliati M. Nucleoside analogue-associated peripheral neuropathy in human immunodeficiency virus infection. J AIDS 1995;9:153-161
18. Fumalaro G, Moretti S, Marcellini S, et al. Acetyl-carnitine deficiency in AIDS patients with neurotoxicity on treatment with antiretroviral nucleoside analogues. AIDS 1997;11:185-190
19. Berger AR, Arezzo JC, Schaumburg HH, et al. 2′,3′-Dideoxycytidine (ddC) toxic neuropathy: A study of 52 patients. Neurology 1993;43:358-362
20. Fuller GN, Jacobs JM, Guiloff RJ. Subclinical peripheral nerve involvement in AIDS: An electrophysiological and pathological study. J Neurol Neurosurg Psychiatry 1991;54:318-324
21. Lange DJ, Britton CB, Younger DS, et al. The neuromuscular manifestations of human immunodeficiency virus infection. Arch Neurol 1988;45:1084-1088
22. World Health Organization. Cancer pain relief, with a guide of opioid availability, 2nd ed. Geneva: World Health Organization, 1996
23. Breitbart W, Rosenfeld BD, Passik SD, et al. The undertreatment of pain in ambulatory AIDS patients. Pain 1996;65:243-249
24. Kieburtz K, Simpson DM, Yiannoustsos C, et al. A randomized trial of amitriptyline and mexiletene for painful neuropathy in HIV infection. Neurology 1998;51:1682-1688
25. Shlay JC, Chaloner D, Max M, et al. Acupunture and amitriptyline for pain due to HIV-related peripheral neuropathy. JAMA 1998;280:1590-1595
26. Khan A, Dorfman D, Scarano A, et al. Treatment of painful peripheral neuropathy in HIV infection with topical agent: Results of an open label study using 5% lidocaine [abstract]. J Neurovirol 1998;4:355
27. Simpson DM, Olney R, McArthur J, et al. A placebo controlled study of lamotrigine in the treatment of painful sensory polyneuropathy associated with HIV infection [abstract]. J Neurovirol 1998;4:366
28. McArthur J, Yiannoutsos C, Simpson DM, et al. Trial of recombinant human nerve growth factor for HIV-associated sensory neuropathy [abstract]. J Neurovirol 1998;4:359
29. Miller RG, Parry CJ, Pfae MW, et al. The spectrum of peripheral neuropathy associated with ARC and AIDS. Muscle Nerve 1988;11:857-863
30. Vendrell J, Heredia C, Pujol M, et al. Guillain-Barre syndrome associated with seroconversion for anti-HTLV-III. Neurology 1987;37:544
31. Mishha BE, Sommers W, Koski CL, et al. Acute inflammatory demyelinating polyneuropathy in the acquired immunodeficiency syndrome. Ann Neurol 1985;18:131-132
32. Morgello S, Simpson DM. Multifocal cytomegalovirus demyelinating polyneuropathy associated with AIDS. Muscle Nerve 1994;17:176-182
33. Cornblath DR, McArthur JC, Kennedy PGE, et al. Inflammatory demyelinating peripheral neuropathies associated with T-cell lymphotropic virus type III infection. Ann Neurol. 1987;21: 32-40
34. Anders HJ, Weiss N, Bogner JR, et al. Ganciclovir and foscarnet efficacy in AIDS-related CMV polyradiculopathy. J Infect Dis 1998;36:29-33
35. Clifford DB, Buller RS, Mohammed S, et al. Use of polymerase chain reaction to demonstrate cytomegalovirus DNA in CSF of patients with human immunodeficiency virus infection. Neurology 1993;43:75-79
36. Eidelberg D, Sotrel A, Vogel H, et al. Progressive polyradiculopathy in acquired immune deficiency syndrome. Neurology 1986; 36:912-916
37. Kim YS, Hollander H. Polyradiculopathy due to cytomegalovirus: Report of two cases in which improvement occurred after prolonged therapy and review of the literature. Clin Infect Dis 1993;17:32-37
38. Said G, Lacroix C, Chemouilli P, et al. Cytomegalovirus neuropathy in acquired immunodeficiency syndrome: A clinical and pathological study. Ann Neurol 1991;29:139-146
39. Roullet E, Assuerus V, Gozlan J, et al. Cytomegalovirus multifocal neuropathy in AIDS: Analysis of 15 consecutive patients. Neurology 1994;44:2174-2182
40. Cohen JR, Laudenslager M. Autonomic nervous system involvement in patients with human immunodeficiency virus infection. Neurology 1989;39:1111-1112
41. Freeman R, Roberts M, Friedman L, et al. Autonomic function and human immunodeficiency virus infection. Neurology 1990;40: 575-580
42. Moulignier A, Authier FJ, Baudrimont M, et al. Peripheral neuropathy in human immunodeficiency virus-infected patients with diffuse infiltrative lymphocytosis syndrome. Ann Neurol 1997; 41:438-445
43. Price RW. Neuropathy complicating diffuse infiltrative lymphocytosis syndrome. Lancet 1998;352:592-594
44. Simpson DM, Citak KA, Godfrey E, et al. Myopathies associated with human immunodeficiency virus and zidovudine: Can their effects be distinguished? Neurology 1993;43:971-976
45. Dalakas MC, Illa I, Pezeshpour GH, et al. Mitochondrial myopathy caused by long term zidovudine therapy. N Engl J Med 1990;322:1098-1105
46. Peters BS, Winer J, Landon DN, et al. Mitochondrial myopathy associated with chronic zidovudine therapy in AIDS. Q J Med 1993;86:5-15
47. Simpson DM, Slasor P, Dafni U, et al. Analysis of myopathy in placebo-controlled zidovudine trial. Muscle Nerve 1997;32: 382-385
48. Morgello S, Wolfe D, Godfrey E, et al. Mitochondrial abnormalities in HIV-associated myopathy. Acta Neuropathol 1995;90:366-374
49. Chad DA, Smith TW, Blumenfield DA, et al. HIV-associated myopathy: Immunocytochemical identification of an HIV antigen (gp41) in muscle macrophages. Ann Neurol 1993;34: 561-565
50. Gherardi R, Florea-Strat A, Fromont G, et al. Cytokine expression in the muscle of HIV-intected patients: Evidence of interleukin-1 alpha accumulation in mitochondria of AZT fibers. Ann Neurol 1994;36:752-758
51. Hassett J, Tagliati M, Golbold, et al. A placebo-controlled study of prednisone in HIV-associated myopathy [abstract]. Neurology 1994;44:A367